caprolactone has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, S; Chen, L; Jiang, Z; Li, A; Liang, Y; Liu, X; Ma, D; Tang, X; Zhang, Y | 1 |
| Khonkarn, R; Mankhetkorn, S; Okonogi, S; Srisa-Nga, K | 1 |
2 other study(ies) available for caprolactone and Cancer of Liver
| Article | Year |
|---|---|
Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma.
Topics: Animals; Antibodies; Antineoplastic Agents; Caproates; Carcinoma, Hepatocellular; Cell Line, Tumor; Glypicans; Hep G2 Cells; Humans; Lactones; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Niacinamide; Phenylurea Compounds; Polyethylene Glycols; Polymers; Sorafenib; Xenograft Model Antitumor Assays | 2018 |
Delivery of Superparamagnetic Polymeric Micelles Loaded With Quercetin to Hepatocellular Carcinoma Cells.
Topics: Antioxidants; Caproates; Carcinoma, Hepatocellular; Drug Carriers; Hep G2 Cells; Humans; Lactones; Liver Neoplasms; Magnetite Nanoparticles; Micelles; Polyethylene Glycols; Quercetin | 2019 |